- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05880030
The Effect of Supplementation of Vitamin D3 on Inflammation Induced by 100 km Running, Iron Metabolism and Erythropoiesis
May 18, 2023 updated by: Gdansk University of Physical Education and Sport
A group of runners received vitamin D (10,000 IU - international unit per day) for two weeks.
The aim of the intervention was to check the effect of vitamin D supplementation on selected parameters of inflammation and iron metabolism in comparison with the placebo group.
Blood was collected before and after supplementation.
Next: before, after 25, 50, 75,100 km running and 12 hours after the run.
The data were subjected to statistical analysis.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
Subjects were randomized to two groups: the experimental one, n = 20 and the placebo one, n = 20 with the same age, experience in running and 25(OH)D level.
The experimental group received vitamin D3 supplementation (around 10,000 UI/day, i.e., 20 droplets -Vigantol medicament, Merck) and the control group received a placebo (20 droplets of sunflower oil, placed in an identical bottle as vitamin D3) for two weeks before a run.
The last vitamin D dose was taken 24 h before the 100 km ultra-marathon.
40 male athletes took part in the 100 km ultra-marathon.
Blood was collected before (day 0) and after supplementation (day 14).
Next (day 15): before, after 25, 50, 75,100 km running and 12 hours after the run (day 16).
The data were subjected to statistical analysis.
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- male
- athletes running ultra-marathons
Exclusion Criteria:
- vitamin D3 supplementation
- multivitamin and iron supplementation
- serum 25(OH)D low < 10 ng/mL
- serum 25(OH)D high > 100 ng/mL
- haemoglobin < 10 g/dL
- other (sports injury, tournament)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Vitamin D
Vigantol 10 000 IU/day (20 droplets) two weeks supplementation (vitamin D3)
|
cholecalciferol 10000 UI
Other Names:
|
Placebo Comparator: Control
sunflower oil, (20 droplets) two weeks supplementation.
|
sunflower oil
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The change in vitamin 25(OH)D level after two-week supplementation.
Time Frame: Day 0 to day 14
|
Measured parameter: vitamin 25(OH)D [ng/ml].
|
Day 0 to day 14
|
The change in parathyroid hormone level after two-week supplementation.
Time Frame: Day 0 to day 14
|
Measured parameter: parathyroid hormone [pg/ml].
|
Day 0 to day 14
|
Observation of changes in inflammatory parameters:interleukin-6 induced by a 100 km run
Time Frame: Day "15 - the run" and day "16 - 12 hours after the run"
|
Measured parameter of inflammatory: interleukin-6 [pg/ml].
Collected blood samples before and after 25, 50, 75 and 100-km run (05 11 2016) and 12h after the run (06 11 2016).
|
Day "15 - the run" and day "16 - 12 hours after the run"
|
Observation of changes in inflammatory parameters: C reactive protein - CRP induced by 100 km running.
Time Frame: Day "15 - the run" and day "16 - 12 hours after the run"
|
Measured parameter of inflammatory: CRP[mg/l].
Collected blood samples before and after 25, 50, 75 and 100-km run (05 11 2016) and 12h after the run (06 11 2016).
|
Day "15 - the run" and day "16 - 12 hours after the run"
|
Observation of changes in creatine kinase level induced by 100 km running.
Time Frame: Day "15 - the run" and day "16 - 12 hours after the run"
|
Measured parameter: creatine kinase [U/l].
Collected blood samples before and after 25, 50, 75 and 100-km run (05 11 2016) and 12h after the run (06 11 2016).
|
Day "15 - the run" and day "16 - 12 hours after the run"
|
Observation of changes in leucocytes induced by 100 km running.
Time Frame: Day "15 - the run" and day "16 - 12 hours after the run"
|
Measured parameters of inflammatory: leukocytes [G/l].
Collected blood samples before and after 25, 50, 75 and 100-km run (05 11 2016) and 12h after the run (06 11 2016).
|
Day "15 - the run" and day "16 - 12 hours after the run"
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Observation of changes in hepcidin level induced by 100 km running.
Time Frame: Day "15 - the run" and day "16 - 12 hours after the run"
|
Measured parameters of iron metabolism: hepcidin [ng/mL].
Collected blood samples before and after 25, 50, 75 and 100-km run (05 11 2016) and 12h after the run (06 11 2016).
|
Day "15 - the run" and day "16 - 12 hours after the run"
|
Observation of changes in serum iron level induced by 100 km running.
Time Frame: Day "15 - the run" and day "16 - 12 hours after the run"
|
Measured serum iron level [µg/dL].Collected blood samples before and after 25, 50, 75 and 100-km run (05 11 2016) and 12h after the run (06 11 2016).
|
Day "15 - the run" and day "16 - 12 hours after the run"
|
Observation of changes in ferritin induced by 100 km running.
Time Frame: Day "15 - the run" and day "16 - 12 hours after the run"
|
Measured parameters of iron metabolism: ferritin [ng/mL].
Collected blood samples before and after 25, 50, 75 and 100-km run (05 11 2016) and 12h after the run (06 11 2016).
|
Day "15 - the run" and day "16 - 12 hours after the run"
|
Observation of changes in erythrocytes level induced by a 100 km run.
Time Frame: Day "15 - the run" and day "16 - 12 hours after the run"
|
Measured erythrocytes level [T/l].Collected blood samples before and after 25, 50, 75 and 100-km run (05 11 2016) and 12 hours after the run (06 11 2016).
|
Day "15 - the run" and day "16 - 12 hours after the run"
|
Observation of changes in reticulocytes induced by a 100 km run.
Time Frame: Day "15 - the run" and day "16 - 12 hours after the run"
|
Measured reticulocytes [promil].
Collected blood samples before and after 25, 50, 75 and 100-km run (05 11 2016) and 12 hours after the run (06 11 2016).
|
Day "15 - the run" and day "16 - 12 hours after the run"
|
Observation of changes in hematocrit induced by a 100 km run.
Time Frame: Day "15 - the run" and day "16 - 12 hours after the run"
|
Measured hematocrit [%].Collected blood samples before and after 25, 50, 75 and 100-km run (05 11 2016) and 12 hours after the run (06 11 2016).
|
Day "15 - the run" and day "16 - 12 hours after the run"
|
Observation of changes in erythropoietin level induced by a 100 km run.
Time Frame: Day "15 - the run" and day "16 - 12 hours after the run"
|
Measured erythropoietin level [mIU - milli-International unit/mL].
Collected blood samples before and after 25, 50, 75 and 100-km run (05 11 2016) and 12 hours after the run (06 11 2016).
|
Day "15 - the run" and day "16 - 12 hours after the run"
|
Observation of changes in erythroferrone level induced by a 100 km run.
Time Frame: Day "15 - the run" and day "16 - 12 hours after the run"
|
Measured erythroferrone level [pg/ml].
Collected blood samples before and after 25, 50, 75 and 100-km run (05 11 2016) and 12 hours after the run (06 11 2016).
|
Day "15 - the run" and day "16 - 12 hours after the run"
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Chair: Katarzyna Kasprowicz, PhD, Gdansk University of Physical Education and Sport
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 19, 2016
Primary Completion (Actual)
November 1, 2022
Study Completion (Actual)
December 31, 2022
Study Registration Dates
First Submitted
December 15, 2022
First Submitted That Met QC Criteria
May 18, 2023
First Posted (Actual)
May 30, 2023
Study Record Updates
Last Update Posted (Actual)
May 30, 2023
Last Update Submitted That Met QC Criteria
May 18, 2023
Last Verified
November 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- AWFiS/2022_2_MK
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
Hasselt UniversityRecruitingHealthy | Healthy AgingBelgium
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
University of PennsylvaniaActive, not recruitingHealthy | Healthy AgingUnited States
-
Chalmers University of TechnologyGöteborg UniversityCompletedHealthy | Nutrition, HealthySweden
-
University of ManitobaNot yet recruitingHealthy | Healthy Diet
Clinical Trials on Cholecalciferol
-
Medical University of South CarolinaTerminatedVitamin D Deficiency | Nutritional DeficiencyUnited States
-
Centre of Postgraduate Medical EducationUnknownInfant, Premature, DiseasesPoland
-
Johns Hopkins UniversityNational Institute on Aging (NIA)TerminatedVitamin D Deficiency | FallsUnited States
-
Rashid Centre for Diabetes and ResearchCompletedObesity | Type 2 Diabetes Mellitus | Hypovitaminosis DUnited Arab Emirates
-
University of PittsburghNational Heart, Lung, and Blood Institute (NHLBI)CompletedCystic Fibrosis | Allergic Bronchopulmonary AspergillosisUnited States
-
University Hospitals Cleveland Medical CenterUniversity of Colorado, DenverCompletedInflammationUnited States
-
University Hospital, AngersMylan LaboratoriesCompleted
-
Medical University of South CarolinaEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompleted
-
Assistance Publique - Hôpitaux de ParisLaboratoire CrinexCompletedRenal Transplant Candidate for Right KidneyFrance